We are live on ! Find out more
PLXP

PLx Pharma Inc. Common Stock
PLXP

Delisted

PLXP was delisted on the 12th of April, 2023.

Back to rankings

19 hedge funds and large institutions have $8.9M invested in PLx Pharma Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

19% more funds holding

Funds holding: 16 → 19 (+3)

11% less capital invested

Capital invested by funds: $10M → $8.9M (-$1.15M)

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

Holders
19
Holders Change
+3
Holders Change %
+18.75%
% of All Funds
0.37%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
3
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FM
Fondren Management
Texas
+$47K
2
HWA
Heritage Way Advisors
Illinois
+$8.05K
3
Renaissance Technologies
Renaissance Technologies
New York
+$6.58K
4
Deutsche Bank
Deutsche Bank
Germany
+$1.85K
5
TRCT
Tower Research Capital (TRC)
New York
+$1.41K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$51.8K
2
Victory Capital Management
Victory Capital Management
Texas
-$8K
3
Bank of America
Bank of America
North Carolina
-$4K
4
Morgan Stanley
Morgan Stanley
New York
-$1.14K
5
BlackRock
BlackRock
New York
-$310
Name Holding Trade Value Shares
Change 		Change in
Stake
PWAM
1
Park West Asset Management
California
$6.44M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.29M – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$306K +$6.58K +1,400 +2%
UOTTAIMCU
4
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$274K +$295K +62,673 New
Millennium Management
5
Millennium Management
New York
$179K -$51.8K -11,015 -21%
HWA
6
Heritage Way Advisors
Illinois
$139K +$8.05K +1,712 +6%
Fayez Sarofim & Co
7
Fayez Sarofim & Co
Texas
$60K – – –
Northern Trust
8
Northern Trust
Illinois
$48K -$108 -23 -0.2%
FM
9
Fondren Management
Texas
$44K +$47K +10,000 New
BlackRock
10
BlackRock
New York
$41K -$310 -66 -0.7%
CWM
11
Cranbrook Wealth Management
Michigan
$33K – – –
Wells Fargo
12
Wells Fargo
California
$27K +$940 +200 +3%
CWA
13
Capital Wealth Alliance
Arizona
$12K +$9.4K +2,000 New
UBS Group
14
UBS Group
Switzerland
$5K – – –
1W
15
1776 Wealth
Georgia
$4K +$4.7K +1,000 New
Morgan Stanley
16
Morgan Stanley
New York
$1K -$1.14K -243 -49%
TRCT
17
Tower Research Capital (TRC)
New York
$1K +$1.41K +300 New
Deutsche Bank
18
Deutsche Bank
Germany
$1K +$1.85K +394 New
Victory Capital Management
19
Victory Capital Management
Texas
– -$8K -1,482 Closed
Bank of America
20
Bank of America
North Carolina
– -$4K -689 Closed
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
– -$160 -34 -63%

PLXP Hedge Fund Activity: Q4 2019 in Review

19 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q4 2019, worth a combined $8.9M — down 11% from $10M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new PLXP positions and 3 closed out — a net gain of 3 holders — while 3 added to existing stakes and 5 trimmed.

The largest buyer was Fondren Management, opening a new position worth an estimated $47K. The largest seller was Millennium Management, cutting an estimated $51.8K.

  • 19 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q4 2019, up from 16 in Q3 2019.
  • Funds reported $8.9M of PLx Pharma Inc. Common Stock stock for Q4 2019, down 11% quarter-over-quarter.
  • 6 funds opened new PLx Pharma Inc. Common Stock positions in Q4 2019 and 3 closed out, a net change of +3 holders.
  • The largest PLx Pharma Inc. Common Stock buyer in Q4 2019 was Fondren Management, an estimated $47K added.
  • The largest PLx Pharma Inc. Common Stock seller in Q4 2019 was Millennium Management, an estimated $51.8K sold.

Based on aggregated 13F filings for Q4 2019.